New models help identify cardiovascular disease risk even before symptoms appear. The researcher's findings also indicate that the risk of heart failure is not evenly distributed across Europe.
By combining two specific markers from a standard cardiac CT scan, researchers were able to identify patients at the highest risk for future heart failure and death.
Not all precancerous lesions will develop into tumours, yet the majority are treated as if they were already breast cancer. A new marker could help identify the relevant cases and avoid overtreatment.
A compact LED module pairs UV-A, green and IR light with a matched photodiode to detect AGE autofluorescence — bringing biochemical risk screening to wearables and point of care testing.
Earlier detection, better outcomes: A new blood test for bowel cancer screening is designed to transform cancer outcomes by moving away from invasive or unpleasant methods.
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.
Pancreatic cancer remains a diagnostic challenge, due to unspecific early symptoms and lack of effective screening tools. A novel AI metabolomics platform could help overcome these issues.
To better distinguish between healthy and diseased gut microbiomes, scientists have created an index that tracks microbial behavior and signals conditions such as colorectal cancer.
Using machine learning, researchers have trained an electronic nose to detect early signs of ovarian cancer in the blood. The method could eventually be used to find many different cancers.
A new study shows that analyzing bacteria from vaginal swab samples taken at delivery could help predict the risk of neonatal sepsis.
Researchers report on decisive steps towards an early diagnosis of Parkinson’s disease: a newly discovered biomarker in the blood could open a window of opportunity for future treatment.
An advanced imaging method that uses the natural glow of tissues could help detect subtle differences in the tissue’s biochemistry, offering a way to earlier detect colorectal cancer via endoscopy.
Scientists developed an AI-based approach to diagnose colorectal cancer from different microbial subgroups in the gut microbiota – a non-invasive and low-cost alternative to colonoscopy screening.
Men assessed as healthy may still have an early form of prostate cancer. Using AI, researchers found signs that were missed in more than 80% of samples of men who later developed cancer.
More clinically relevant tumors detected at an earlier stage and at lower costs: New research finds that AI can replace the second radiologist in the Dutch breast cancer screening program.
Tumor vesicles may serve as early indicators of cancer and help monitor the effectiveness of treatments. Now, researchers discovered a new way to detect these vesicles.
A new AI tool has been shown to accurately predict who would go on to develop leaks in the heart valves – conditions known as regurgitant valvular heart diseases, at a very early stage from an ECG.
The earlier Alzheimer's disease is detected, the more effective treatments become. Now, a Finnish study shows that signs related to Alzheimer’s may already be found in the brain in middle age.
A neural network AI has been trained to detect cardiac amyloidosis from a single echocardiogram video of the heart's apical four-chamber view and differentiate it from similar heart conditions.
